Prevalence of hypovitaminosis D in elderly women in Italy: clinical consequences and risk factors.

PubWeight™: 1.36‹?› | Rank: Top 10%

🔗 View Article (PMID 12856111)

Published in Osteoporos Int on July 11, 2003

Authors

G Isaia1, R Giorgino, G B Rini, M Bevilacqua, D Maugeri, S Adami

Author Affiliations

1: Department of Internal Medicine, University of Turin, Italy.

Associated clinical trials:

Reference Interval of Vitamin D of Coastal Fishermen in Cox's Bazar District of Bangladesh | NCT04986319

Articles citing this

Global vitamin D status and determinants of hypovitaminosis D. Osteoporos Int (2009) 5.43

Very low levels of vitamin D in systemic sclerosis patients. Clin Rheumatol (2010) 2.78

Skeletal and nonskeletal effects of vitamin D: is vitamin D a tonic for bone and other tissues? Osteoporos Int (2014) 2.74

Relationship between vitamin D, parathyroid hormone, and bone health. J Clin Endocrinol Metab (2010) 1.90

Optimal vitamin D status and serum parathyroid hormone concentrations in African American women. Am J Clin Nutr (2006) 1.67

Vitamin D status in relation to obesity, bone mineral density, bone turnover markers and vitamin D receptor genotypes in healthy Saudi pre- and postmenopausal women. Osteoporos Int (2010) 1.55

Vitamin D: An overview of vitamin D status and intake in Europe. Nutr Bull (2014) 1.52

Vitamin D status and response to treatment in post-menopausal osteoporosis. Osteoporos Int (2008) 1.26

Serum 25-hydroxyvitamin D and physical function in older adults: the Cardiovascular Health Study All Stars. J Am Geriatr Soc (2011) 1.19

Knowledge of vitamin D and perceptions and attitudes toward sunlight among Chinese middle-aged and elderly women: a population survey in Hong Kong. BMC Public Health (2006) 1.18

Vitamin D deficiency in rheumatoid arthritis: prevalence, determinants and associations with disease activity and disability. Arthritis Res Ther (2010) 1.16

Prevalence of vitamin D depletion among subjects seeking advice on osteoporosis: a five-year cross-sectional study with public health implications. Osteoporos Int (2007) 1.06

Vitamin D and physical performance in elderly subjects: the Pro.V.A study. PLoS One (2012) 1.01

Vitamin D-insufficiency: An estimate of the situation in Germany. Dermatoendocrinol (2012) 0.99

Vitamin d deficiency in healthy male population: results of the Iranian multi- center osteoporosis study. Iran J Public Health (2010) 0.98

Changes in bone mineral parameters, vitamin D metabolites, and PTH measurements with varying chronic kidney disease stages. J Bone Miner Metab (2010) 0.93

The potential role of vitamin D enhanced foods in improving vitamin D status. Nutrients (2011) 0.92

Vitamin D and the cardiovascular system. Osteoporos Int (2013) 0.92

Bone and bone marrow pro-osteoclastogenic cytokines are up-regulated in osteoporosis fragility fractures. Osteoporos Int (2010) 0.91

Hypovitaminosis D, impaired bone turnover and low bone mass are common in patients with peripheral arterial disease. Osteoporos Int (2004) 0.90

Altered glucose metabolism rather than naive type 2 diabetes mellitus (T2DM) is related to vitamin D status in severe obesity. Cardiovasc Diabetol (2014) 0.90

Clinical utility of laboratory testing in women with osteoporosis. Osteoporos Int (2004) 0.89

Factors Affecting 25-Hydroxyvitamin D Concentration in Response to Vitamin D Supplementation. Nutrients (2015) 0.89

Use of a questionnaire to assess vitamin D status in young adults. Public Health Nutr (2008) 0.88

Inverse association between dietary vitamin D and risk of cutaneous melanoma in a northern Italy population. Nutr Cancer (2011) 0.87

Serum 25-OH Vitamin D in relation to Bone Mineral Density and Bone Turnover. Int J Endocrinol (2014) 0.87

Serum 25-hydroxyvitamin D levels and activities of daily living in noninstitutionalized elderly Japanese requiring care. J Bone Miner Metab (2005) 0.86

Vitamin D status among adults in Germany--results from the German Health Interview and Examination Survey for Adults (DEGS1). BMC Public Health (2015) 0.85

Prevalence of serum vitamin D deficiency and insufficiency in cancer: Review of the epidemiological literature. Exp Ther Med (2011) 0.85

Vitamin d status in patients operated for primary hyperparathyroidism: comparison of patients from southern and northern europe. Int J Endocrinol (2013) 0.84

Vitamin D in "early" primary Sjögren's syndrome: does it play a role in influencing disease phenotypes? Rheumatol Int (2013) 0.81

Calcium metabolism and vitamin D in the extreme longevity. Exp Gerontol (2007) 0.81

Low 25-hydroxyvitamin D predicts the onset of mobility limitation and disability in community-dwelling older adults: the Health ABC Study. J Gerontol A Biol Sci Med Sci (2012) 0.80

Vitamins and type 2 diabetes mellitus. Endocr Metab Immune Disord Drug Targets (2015) 0.80

Is Low Serum Vitamin D Associated with Early Dental Implant Failure? A Retrospective Evaluation on 1625 Implants Placed in 822 Patients. Mediators Inflamm (2016) 0.79

Relationship between 25-hydroxyvitamin D and metabolic syndrome among Jordanian adults. Nutr Res Pract (2011) 0.78

Higher visceral fat area increases the risk of vitamin D insufficiency and deficiency in Chinese adults. Nutr Metab (Lond) (2015) 0.78

Hypovitaminosis D and response to cholecalciferol supplementation in patients with autoimmune and non-autoimmune rheumatic diseases. Rheumatol Int (2011) 0.78

Vitamin D supplementation in fractured patient: how, when and why. Clin Cases Miner Bone Metab (2009) 0.76

Low 25(OH) D serum levels are related with hip fracture in postmenopausal women: a matched case-control study. J Transl Med (2015) 0.76

Serum levels of 25-hydroxyvitamin D and functional outcome among postmenopausal women with hip fracture. PLoS One (2015) 0.76

25-hydroxyvitamin D, parathyroid hormone, and functional recovery after hip fracture in elderly patients. J Bone Miner Metab (2006) 0.76

Biological effects of various regimes of 25-hydroxyvitamin D3 (calcidiol) administration on bone mineral metabolism in postmenopausal women. Clin Cases Miner Bone Metab (2009) 0.76

Stability of Vitamin D3 in fortified yoghurt and yoghurt drink (Doogh). Adv Biomed Res (2016) 0.75

The initiative on hip fractures of the Veneto Region. Clin Cases Miner Bone Metab (2012) 0.75

Vitamin D and autoimmune rheumatic diseases. Clin Rheumatol (2011) 0.75

Vitamin D status in Bosnia and Herzegovina: the cross-sectional epidemiological analysis. Osteoporos Int (2016) 0.75

Articles cited by this

Vitamin D3 and calcium to prevent hip fractures in the elderly women. N Engl J Med (1992) 9.86

Hypovitaminosis D in medical inpatients. N Engl J Med (1998) 9.13

Effect of calcium and vitamin D supplementation on bone density in men and women 65 years of age or older. N Engl J Med (1997) 6.88

Vitamin D supplementation, 25-hydroxyvitamin D concentrations, and safety. Am J Clin Nutr (1999) 6.64

Serum 25-hydroxyvitamin D status of adolescents and adults in two seasonal subpopulations from NHANES III. Bone (2002) 6.02

Serum vitamin D concentrations among elderly people in Europe. Lancet (1995) 3.19

A global study of vitamin D status and parathyroid function in postmenopausal women with osteoporosis: baseline data from the multiple outcomes of raloxifene evaluation clinical trial. J Clin Endocrinol Metab (2001) 3.16

Differences in vitamin D status between countries in young adults and the elderly. Am J Med (1992) 2.67

Effect of vitamin D supplementation on wintertime and overall bone loss in healthy postmenopausal women. Ann Intern Med (1991) 2.61

Vitamin D and bone health in the elderly. Am J Clin Nutr (1982) 2.21

Vitamin D status and redefining serum parathyroid hormone reference range in the elderly. J Clin Endocrinol Metab (2001) 2.05

Hypovitaminosis D in a sunny country: relation to lifestyle and bone markers. J Bone Miner Res (2000) 1.88

Longitudinal evaluation of vitamin D status in healthy subjects from southern Italy: seasonal and gender differences. Osteoporos Int (2001) 1.39

Histomorphometric profile and vitamin D status in patients with femoral neck fracture. Metab Bone Dis Relat Res (1982) 1.27

Vitamin D status and sex hormone binding globulin: determinants of bone turnover and bone mineral density in elderly women. J Bone Miner Res (1995) 1.18

High prevalence of hypovitaminosis D among free-living postmenopausal women referred to an osteoporosis outpatient clinic in northern Italy for initial screening. Osteoporos Int (1999) 1.02

Design, methods and participation. Euronut SENECA investigators. Eur J Clin Nutr (1991) 0.97

Life-style: physical activities and activities of daily living. Euronut SENECA investigators. Eur J Clin Nutr (1991) 0.82

Vitamin D deficiency and osteopathies. Osteoporos Int (1998) 0.81

Articles by these authors

Effect of risedronate on the risk of hip fracture in elderly women. Hip Intervention Program Study Group. N Engl J Med (2001) 9.57

Recognition by ELAM-1 of the sialyl-Lex determinant on myeloid and tumor cells. Science (1990) 3.74

Strontium ranelate reduces the risk of nonvertebral fractures in postmenopausal women with osteoporosis: Treatment of Peripheral Osteoporosis (TROPOS) study. J Clin Endocrinol Metab (2005) 3.67

Alendronate for the treatment of osteoporosis in men. N Engl J Med (2000) 3.11

Determinants of adherence to osteoporosis treatment in clinical practice. Osteoporos Int (2006) 2.79

The effect of teriparatide [human parathyroid hormone (1-34)] therapy on bone density in men with osteoporosis. J Bone Miner Res (2003) 2.50

A multicenter cross sectional study on bone mineral density in rheumatoid arthritis. Italian Study Group on Bone Mass in Rheumatoid Arthritis. J Rheumatol (2000) 2.47

Prevention of nonvertebral fractures by alendronate. A meta-analysis. Alendronate Osteoporosis Treatment Study Groups. JAMA (1997) 2.46

The time course of a hypercalcaemic crisis in acute primary hyperparathyroidism. Lancet (1984) 2.21

An immunoendocrinological hypothesis of HIV infection. Lancet (1994) 2.19

Long-term nasal intermittent positive pressure ventilation in advanced Duchenne's muscular dystrophy. Chest (1994) 2.01

Gastroepiploic artery free graft for coronary bypass. Eur J Cardiothorac Surg (1990) 1.94

The Global Longitudinal Study of Osteoporosis in Women (GLOW): rationale and study design. Osteoporos Int (2009) 1.85

Quantitative heel ultrasound in a population-based study in Italy and its relationship with fracture history: the ESOPO study. Osteoporos Int (2005) 1.80

Efficacy and safety of daily risedronate in the treatment of corticosteroid-induced osteoporosis in men and women: a randomized trial. European Corticosteroid-Induced Osteoporosis Treatment Study. J Bone Miner Res (2000) 1.80

Ibandronate for the prevention of nonvertebral fractures: a pooled analysis of individual patient data. Osteoporos Int (2008) 1.76

High prevalence of hypovitaminosis D in female type 2 diabetic population. Diabetes Care (2001) 1.74

Miglustat in patients with Niemann-Pick disease Type C (NP-C): a multicenter observational retrospective cohort study. Mol Genet Metab (2009) 1.72

Selectins: a family of adhesion receptors. Cell (1991) 1.72

Sleep-related breathing disorders, loud snoring and excessive daytime sleepiness in obese subjects. Int J Obes Relat Metab Disord (2001) 1.70

Effect of shift work on body mass index: results of a study performed in 319 glucose-tolerant men working in a Southern Italian industry. Int J Obes Relat Metab Disord (2003) 1.69

Efficacy and tolerability of once-monthly oral ibandronate in postmenopausal osteoporosis: 2 year results from the MOBILE study. Ann Rheum Dis (2005) 1.66

Therapeutic equivalence of alendronate 70 mg once-weekly and alendronate 10 mg daily in the treatment of osteoporosis. Alendronate Once-Weekly Study Group. Aging (Milano) (2000) 1.59

Incidence and costs of hip fractures compared to acute myocardial infarction in the Italian population: a 4-year survey. Osteoporos Int (2006) 1.54

From endothelial dysfunction to atherosclerosis. Autoimmun Rev (2010) 1.47

Bone loss in response to long-term glucocorticoid therapy. Bone Miner (1990) 1.44

Spironolactone, but not flutamide, administration prevents bone loss in hyperandrogenic women treated with gonadotropin-releasing hormone agonist. J Clin Endocrinol Metab (1999) 1.43

Fat depot-related differences in gene expression, adiponectin secretion, and insulin action and signalling in human adipocytes differentiated in vitro from precursor stromal cells. Diabetologia (2007) 1.42

Tolerability of risedronate in postmenopausal women intolerant of alendronate. Aging (Milano) (2001) 1.40

Free triiodothyronine and thyroid stimulating hormone are directly associated with waist circumference, independently of insulin resistance, metabolic parameters and blood pressure in overweight and obese women. Clin Endocrinol (Oxf) (2007) 1.38

Natural history of Niemann-Pick disease type C in a multicentre observational retrospective cohort study. Mol Genet Metab (2009) 1.34

Osteoporosis in young adults: pathophysiology, diagnosis, and management. Osteoporos Int (2012) 1.25

Altered bone metabolism in inflammatory bowel disease: there is a difference between Crohn's disease and ulcerative colitis. J Intern Med (2000) 1.24

C-reactive protein is independently associated with total body fat, central fat, and insulin resistance in adult women. Int J Obes Relat Metab Disord (2001) 1.23

Two-year results of once-weekly administration of alendronate 70 mg for the treatment of postmenopausal osteoporosis. J Bone Miner Res (2002) 1.22

Low serum levels of 25-hydroxy vitamin D in adults affected by thalassemia major or intermedia. Bone (2006) 1.18

Usefulness of magnetic resonance imaging for diagnosis of acute myocarditis in infants and children, and comparison with endomyocardial biopsy. Am J Cardiol (1991) 1.15

Sperm count suppression without endocrine dysfunction in lead-exposed men. Arch Environ Health (1987) 1.15

Radioimmunoassay of 1,25-dihydroxy vitamin D2: studies on the metabolism of vitamin D2 in man. Clin Endocrinol (Oxf) (1983) 1.13

Phenotypic variation in hyperandrogenic women influences the findings of abnormal metabolic and cardiovascular risk parameters. J Clin Endocrinol Metab (2005) 1.10

The anti-inflammatory drug nimesulide rescues alpha-1-proteinase inhibitor from oxidative inactivation by phagocytosing neutrophils. Respiration (1992) 1.08

Hypomagnesaemia: studies of parathyroid hormone secretion and function. Clin Endocrinol (Oxf) (1984) 1.08

Effect of metoclopramide, a dopaminergic inhibitor, on renin and aldosterone in idiopathic edema: possible therapeutic approach with levodopa and carbidopa. J Clin Endocrinol Metab (1979) 1.06

Lumiracoxib is effective in the treatment of osteoarthritis of the knee: a 13 week, randomised, double blind study versus placebo and celecoxib. Ann Rheum Dis (2004) 1.06

Immunosenescence: a review. Arch Gerontol Geriatr (2001) 1.05

Plasma leptin is independently associated with the intima-media thickness of the common carotid artery. Int J Obes Relat Metab Disord (2001) 1.04

Fracture incidence and changes in quality of life in women with an inadequate clinical outcome from osteoporosis therapy: the Observational Study of Severe Osteoporosis (OSSO). Osteoporos Int (2007) 1.03

Aspirin stimulates insulin and glucagon secretion and increases glucose tolerance in normal and diabetic subjects. Diabetes (1978) 1.03

Prevalence and correlates of vertebral fractures in adults with cystic fibrosis. Bone (2004) 1.02

High prevalence of hypovitaminosis D among free-living postmenopausal women referred to an osteoporosis outpatient clinic in northern Italy for initial screening. Osteoporos Int (1999) 1.02

Plasma-prolactin and cimetidine. Lancet (1977) 1.02

[Incidence and socioeconomic burden of hip fractures in Italy]. Reumatismo (2005) 1.02

Dichloromethylene-diphosphonate in patients with prostatic carcinoma metastatic to the skeleton. J Urol (1985) 1.02

Immunopathology of leishmaniasis: an update. Int J Immunopathol Pharmacol (2007) 1.01

Intravenous clodronate in the treatment of reflex sympathetic dystrophy syndrome. A randomized, double blind, placebo controlled study. J Rheumatol (2000) 1.01

Endothelial dysfunction in PCOS: role of obesity and adipose hormones. Am J Med (2006) 1.01

Effects of strontium ranelate on spinal osteoarthritis progression. Ann Rheum Dis (2007) 1.01

Disease-specific perception of fracture risk and incident fracture rates: GLOW cohort study. Osteoporos Int (2013) 1.00

Validation of the Italian version of the WHO-Well-Being Questionnaire (WHO-WBQ) and the WHO-Diabetes Treatment Satisfaction Questionnaire (WHO-DTSQ). Diabetes Nutr Metab (2004) 1.00

Relation between adiponectin and bone mineral density in elderly post-menopausal women: role of body composition, leptin, insulin resistance, and dehydroepiandrosterone sulfate. J Endocrinol Invest (2008) 1.00

Glioblastoma in elderly patients: safety and efficacy of adjuvant radiotherapy with concomitant temozolomide. Arch Gerontol Geriatr (2009) 0.99

Randomized placebo-controlled trial comparing fluticasone aqueous nasal spray in mono-therapy, fluticasone plus cetirizine, fluticasone plus montelukast and cetirizine plus montelukast for seasonal allergic rhinitis. Clin Exp Allergy (2004) 0.99

High systolic blood pressure increases prevalence and severity of retinopathy in NIDDM patients. Diabetes Care (1992) 0.98

Association of dietary patterns with insulin resistance and clinically silent carotid atherosclerosis in apparently healthy people. Eur J Clin Nutr (2013) 0.98

Correlates of increased lean muscle mass in women with polycystic ovary syndrome. Eur J Endocrinol (2009) 0.98

Risedronate increases bone density and reduces vertebral fracture risk within one year in men on corticosteroid therapy. Calcif Tissue Int (2001) 0.96

Relationship among VDR (BsmI and FokI), COLIA1, and CTR polymorphisms with bone mass, bone turnover markers, and sex hormones in men. Calcif Tissue Int (2002) 0.95

Immunomodulatory effects of 1,25-dihydroxyvitamin D3 on TH1/TH2 cytokines in inflammatory bowel disease: an in vitro study. Int J Immunopathol Pharmacol (2009) 0.95

Age-related cortical bone loss at the metacarpal. Calcif Tissue Int (1997) 0.95

Exploration of the testis in infertile men. Relationships among serum levels of FSH, LH, 17-alpha-OH-progesterone and testosterone. Andrologia (1990) 0.95

Atherogenic lipoprotein phenotype and LDL size and subclasses in women with gestational diabetes. Diabet Med (2008) 0.95

Sperm count suppression without endocrine dysfunction in lead-exposed men. Arch Environ Health (1987) 0.94

Identification of alpha 1-adrenergic receptors on sarcolemma from normal subjects and patients with idiopathic dilated cardiomyopathy: characteristics and linkage to GTP-binding protein. Circ Res (1989) 0.94

Long-term effects of a treatment course with oral alendronate of postmenopausal osteoporosis. J Bone Miner Res (1994) 0.94

Association of CTR and COLIA1 alleles with BMD values in peri- and postmenopausal women. Calcif Tissue Int (2000) 0.93

Treatment of morbid obesity by intraparietogastric administration of botulinum toxin: a randomized, double-blind, controlled study. Int J Obes (Lond) (2006) 0.93

Long term follow up of children with myocarditis treated by immunosuppression and of children with dilated cardiomyopathy. Heart (2004) 0.93

Biophysical and endocrine-metabolic changes during menopausal hot flashes: increase in plasma free fatty acid and norepinephrine levels. Gynecol Obstet Invest (1989) 0.93

Effects of oral alendronate in elderly patients with osteoporosis and mild primary hyperparathyroidism. J Bone Miner Res (2001) 0.93

Metabolic syndrome in polycystic ovary syndrome (PCOS): lower prevalence in southern Italy than in the USA and the influence of criteria for the diagnosis of PCOS. Eur J Endocrinol (2006) 0.93

Treatment of Paget's disease of bone with intravenous 4-amino-1-hydroxybutylidene-1,1-bisphosphonate. Calcif Tissue Int (1986) 0.92

Characterization of patients with an inadequate clinical outcome from osteoporosis therapy: the Observational Study of Severe Osteoporosis (OSSO). QJM (2006) 0.92

Tilted implants in the immediate loading rehabilitation of the maxilla: a systematic review. J Dent Res (2012) 0.91

Familial benign hypercalcaemia. Study of a large family. Q J Med (1983) 0.91

Metoclopramide increases plasma aldosterone concentration in man. J Clin Endocrinol Metab (1977) 0.91

Gitelman disease associated with growth hormone deficiency, disturbances in vasopressin secretion and empty sella: a new hereditary renal tubular-pituitary syndrome? Pediatr Res (1999) 0.91

Lower insulin sensitivity as an independent risk factor for carotid wall thickening in normotensive, non-diabetic, non-smoking normal weight and obese premenopausal women. Int J Obes Relat Metab Disord (2000) 0.91

Prevalence and mechanisms of diurnal hypercapnia in a sample of morbidly obese subjects with obstructive sleep apnoea. Respir Med (2000) 0.90

Within-patient variability of hormone and cytokine concentrations in heart failure. Pharmacol Res (1998) 0.90

"The Linosa Study": epidemiological and heritability data of the metabolic syndrome in a Caucasian genetic isolate. Nutr Metab Cardiovasc Dis (2009) 0.90

Glucocorticoids and Th-1, Th-2 type cytokines in rheumatoid arthritis, osteoarthritis, asthma, atopic dermatitis and AIDS. Clin Exp Rheumatol (1997) 0.90

Cardiomyopathy and multicore myopathy with accumulation of intermediate filaments. Eur J Pediatr (1990) 0.89

Effects of streptozocin diabetes and diabetes treatment by islet transplantation on in vivo insulin signaling in rat heart. Diabetes (2001) 0.89

Gender differences in serum leptin in obese people: relationships with testosterone, body fat distribution and insulin sensitivity. Eur J Clin Invest (1997) 0.89

[Antibodies against Toxocara canis in human serum from western Sicily]. Boll Ist Sieroter Milan (1989) 0.89

Increase in both pro-thrombotic and anti-thrombotic factors in obese premenopausal women: relationship with body fat distribution. Int J Obes Relat Metab Disord (1997) 0.89

Prevalence of left-sided obstructive lesions in patients with atrioventricular canal without Down's syndrome. J Thorac Cardiovasc Surg (1986) 0.89

Cardiac catheterization through the internal jugular vein in pediatric patients. An alternative to the usual femoral vein access. Chest (1992) 0.88